HHIP and hepatocellular carcinoma: The results showed that HCC patients with low HHIP expression level had shorter relapse-free survival (RFS), progression-free survival (PFS), and disease-specific survival (DSS) (Fig. 7A–C), indicating that low HHIP expression was associated with a poor outcome in HCC.